Browsing by Author Camins A.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 6 of 6
TitleAuthor(s)???itemlist.dc.contributor.other??????itemlist.dc.contributor.editor???
GSK3? inhibition is involved in the neuroprotective effects of cyclin-dependent kinase inhibitors in neuronsDe La Torre A.V; Junyent F; Folch J; Pelegri C; Vilaplana J; Auladell C; Beas-Zárate, Carlos; Pallas M; Verdaguer E; Camins A.--
GSK3β inhibition is involved in the neuroprotective effects of cyclin-dependent kinase inhibitors in neuronsDe La Torre A.V; Junyent F; Folch J; Pelegri C; Vilaplana J; Auladell C; Beas-Zárate, Carlos; Pallas M; Verdaguer E; Camins A.--
High-fat diet-induced deregulation of hippocampal insulin signaling and mitochondrial homeostasis deficiences contribute to Alzheimer disease pathology in rodentsPetrov D; Pedros I; Artiach G; Sureda F.X; Barroso E; Pallas M; Casadesus G; Beas-Zárate, Carlos; Carro E; Ferrer I; Vazquez-Carrera M; Folch J; Camins A.--
High-fat diet-induced deregulation of hippocampal insulin signaling and mitochondrial homeostasis deficiences contribute to Alzheimer disease pathology in rodentsPetrov D; Pedros I; Artiach G; Sureda F.X; Barroso E; Pallas M; Casadesus G; Beas-Zárate, Carlos; Carro E; Ferrer I; Vazquez-Carrera M; Folch J; Camins A.--
Masitinib for the treatment of mild to moderate Alzheimer's diseaseFolch J; Petrov D; Ettcheto M; Pedros I; Abad S; Beas-Zárate, Carlos; Lazarowski A; Marin M; Olloquequi J; Auladell C; Camins A.--
Masitinib for the treatment of mild to moderate Alzheimer's diseaseFolch J; Petrov D; Ettcheto M; Pedros I; Abad S; Beas-Zárate, Carlos; Lazarowski A; Marin M; Olloquequi J; Auladell C; Camins A.--